Module Database Search
MODULE DESCRIPTOR | |||
---|---|---|---|
Module Title | |||
Applied Pharmacology | |||
Reference | AS3904 | Version | 4 |
Created | August 2021 | SCQF Level | SCQF 9 |
Approved | August 2014 | SCQF Points | 15 |
Amended | August 2021 | ECTS Points | 7.5 |
Aims of Module | |||
---|---|---|---|
To develop an understanding of pharmacological principles which underpin clinical biochemical and toxicological screening. |
Learning Outcomes for Module | |
---|---|
On completion of this module, students are expected to be able to: | |
1 | Recognise and discuss the pharmacological targets that may modulate biomarkers used in biochemical and toxicological screening. |
2 | Utilise knowledge and understanding acquired from Learning Outcome 1 to underpin the integration of pharmacological principles in the context of drug absorption, drug distribution, drug metabolism and excretion. |
3 | Manipulate, present, interpret and discuss experimental data based on knowledge from Learning Outcomes 1 & 2. |
Indicative Module Content |
---|
Pharmacodynamics and pharmacokinetics of drugs of abuse using selected examples (including recreational drug use and performance enhancing drugs). Drug-receptor interactions outlining the roles of biotransformation and genetic polymorphisms in ADME. Biomarkers and drug metabolism, in clinical/toxicological screening. |
Module Delivery |
---|
Lectures, coursework sessions (which include problem solving exercises, data collection and analysis), tutorial sessions and directed study (including use of pharmacological computer packages, directed reading and self-assessment exercises). |
Indicative Student Workload | Full Time | Part Time |
---|---|---|
Contact Hours | 40 | N/A |
Non-Contact Hours | 110 | N/A |
Placement/Work-Based Learning Experience [Notional] Hours | N/A | N/A |
TOTAL | 150 | N/A |
Actual Placement hours for professional, statutory or regulatory body |   |   |
ASSESSMENT PLAN | |||||
---|---|---|---|---|---|
If a major/minor model is used and box is ticked, % weightings below are indicative only. | |||||
Component 1 | |||||
Type: | Coursework | Weighting: | 60% | Outcomes Assessed: | 1, 2, 3 |
Description: | Requires the completion of an appropriate case study. | ||||
Component 2 | |||||
Type: | Examination | Weighting: | 40% | Outcomes Assessed: | 1, 2 |
Description: | Unseen, closed book examination. |
MODULE PERFORMANCE DESCRIPTOR | |
---|---|
Explanatory Text | |
The first grade represents Component 1 (CW1) weighted as major and the second, Component 2 (EX1), weighted as minor. A minimum of Module Grade D is required to pass the module, with compensation of grade E in C1 or C2 permitted. Non-submission of either component will result in an NS grade. | |
Module Grade | Minimum Requirements to achieve Module Grade: |
A | AA, AB |
B | AC, AD, BA, BB, BC, CA |
C | AE, BD, BE, CB, CC, CD, DA, DB, EA |
D | CE, DC, DD, DE, EB, EC |
E | AF, BF, CF, DF, ED, EE, EF, FA, FB, FC, FD |
F | FE, FF |
NS | Non-submission of work by published deadline or non-attendance for examination |
Module Requirements | |
---|---|
Prerequisites for Module | Successful completion of Stage 2 of the course, or equivalent. |
Corequisites for module | None. |
Precluded Modules | None. |
INDICATIVE BIBLIOGRAPHY | |
---|---|
1 | BORON, W.F. and BOULPAEP, E.L. 2004. Medical Physiology. Oxford: Saunders-Elsevier Science. |
2 | GOLAN,D.E et al. 2012. Principles of Pharmacology (3rd Ed.). Baltimore: Lippincott, Williams and Wilkins. |